The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Recruiting · NCT06030843 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cardio-renal syndrome, cardiovascular disorder, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-16 | NCT06030843 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chulalongkorn University | 53 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Faculty of Medicine, Chulalongkorn University | Bangkok | Thailand | 1 |